Compounds > mansonone f
Page last updated: 2024-08-26

mansonone f and sesquiterpenes

mansonone f has been researched along with sesquiterpenes in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cui, Z; Ikejima, T; Onodera, S; Tashiro, S; Wang, D; Xia, M1
Chae, JH; Choi, NS; Hyun, SS; Jeong, JM; Kim, SH; Kim, SN; Lee, KO; Lee, YS; Seo, SY; Shin, DY; Suh, YG1
Choi, EC; Choi, SH; Han, SM; Hyun, SS; Kim, SN; Lee, DS; Li, F; Min, KH; Shin, DY; Suh, YG1
Banerjee, AK; Ng, PS1
Gu, LQ; Huang, SL; Huang, ZS; Lee, KS; Li, MM; Liu, Z1
Chen, SB; Gu, LQ; Huang, SL; Huang, ZH; Huang, ZS; Li, D; Ou, JB; Ou, TM; Shen, LL; Tan, JH; Wu, WB1

Other Studies

6 other study(ies) available for mansonone f and sesquiterpenes

ArticleYear
Cytotoxic effects of mansonone E and F isolated from Ulmus pumila.
    Biological & pharmaceutical bulletin, 2004, Volume: 27, Issue:7

    Topics: Adult; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cells, Cultured; Dose-Response Relationship, Drug; Growth Inhibitors; HeLa Cells; Humans; Leukocytes, Mononuclear; Naphthoquinones; Plant Extracts; Plant Roots; Sesquiterpenes; Ulmus

2004
Syntheses and anti-MRSA activities of the C3 analogs of mansonone F, a potent anti-bacterial sesquiterpenoid: insights into its structural requirements for anti-MRSA activity.
    Bioorganic & medicinal chemistry letters, 2004, Sep-06, Volume: 14, Issue:17

    Topics: Anti-Bacterial Agents; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Naphthoquinones; Sesquiterpenes; Staphylococcus aureus; Structure-Activity Relationship

2004
The structure-activity relationships of mansonone F, a potent anti-MRSA sesquiterpenoid quinone: SAR studies on the C6 and C9 analogs.
    Bioorganic & medicinal chemistry letters, 2006, Jan-01, Volume: 16, Issue:1

    Topics: Anti-Infective Agents; Drug Resistance, Bacterial; Methicillin; Models, Chemical; Naphthoquinones; Quinones; Sesquiterpenes; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin

2006
Alternative procedure for the synthesis of Mansonone F and Biflorin precursor.
    Natural product research, 2006, May-20, Volume: 20, Issue:6

    Topics: Ketones; Magnetic Resonance Spectroscopy; Mass Spectrometry; Naphthols; Naphthoquinones; Pyrans; Sesquiterpenes; Spectrophotometry, Infrared; Tetralones

2006
Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity.
    Chemico-biological interactions, 2009, Jan-15, Volume: 177, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Cytochromes c; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Flow Cytometry; HeLa Cells; Humans; Intracellular Space; Kinetics; NADPH Oxidases; Naphthoquinones; Necrosis; Reactive Oxygen Species; Sesquiterpenes; Superoxides; Thioredoxin-Disulfide Reductase

2009
Synthesis and evaluation of mansonone F derivatives as topoisomerase inhibitors.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:8

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antigens, Neoplasm; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Survival; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Etoposide; Humans; Inhibitory Concentration 50; Lung Neoplasms; Naphthoquinones; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Plasmids; Pyrans; Quinones; Sesquiterpenes; Structure-Activity Relationship; Telomerase; Topoisomerase Inhibitors

2011